Remus Pharmaceuticals Limited (NSE:REMUS)
India · Delayed Price · Currency is INR 799.00
-21.50 (-2.62%)
Nov 11, 2026, 1:10 PM IST
Remus Pharmaceuticals Market Cap
Remus Pharmaceuticals has a market cap or net worth of 9.42 billion as of November 10, 2026. It is the 24,755th most valuable company in the world and the 1,631st biggest in India. Its market cap has decreased by 0.88% in one year.
Market Cap
9.42B
Enterprise Value
9.53B
Revenue
10.69B
Global Rank
Country Rank
#1,631 India
PE Ratio
23.65
ChartMarket Cap Chart
Since May 29, 2023, Remus Pharmaceuticals's market cap has increased from 2.65B to 9.42B, an increase of 255.74%. That is a compound annual growth rate of 44.35%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 11, 2026 | 9.42B | 15.02% |
| Dec 31, 2025 | 8.19B | -44.37% |
| Dec 31, 2024 | 14.72B | 30.53% |
| Dec 29, 2023 | 11.27B | 325.95% |
| May 29, 2023 | 2.65B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Accent Microcell | 14.46B |
| Infinium Pharmachem | 4.21B |
| Sotac Pharmaceuticals | 1.44B |
| Quest Laboratories | 1.41B |
| Vilin Bio Med | 831.89M |
| Zenith Drugs | 679.09M |
| Medicamen Organics | 315.10M |
| Sunrest Lifescience | 153.20M |